Drugs / Caphosol
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT02807337 | Aug 2016 → Dec 2019 | cancer | Tampere University Hospital | Completed | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT02539342 | Oct 2016 → Mar 2017 | chemotherapy-induced oral mucositis | Medical College of Wisconsin | Terminated | No outcome recorded |
| Phase 3 | NCT01305200 | Mar 2011 → Jun 2015 | Burkitt lymphoma, Hodgkins lymphoma, childhood acute lymphoblastic leukemia, childhood acute myeloid leukemia +11 | Children's Oncology Group | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT01046812 | Sep 2009 → Dec 2011 | — | New York Head & Neck Institute | Completed | No outcome recorded |
Also used as a comparator or background therapy in 4 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT03399331 Background | Jul 2017 → Dec 2021 | chemotherapy-induced oral mucositis, leukemia | American University of Beirut Medical Center | Completed | No outcome recorded |
| Phase 1/22 trials | ||||||
| Phase 1/2 | NCT02589145 Background | Jun 2016 → Apr 2019 | lymphoma | M.D. Anderson Cancer Center | Terminated | No outcome recorded |
| Phase 1/2 | NCT02701673 Background | Jun 2016 → Jun 2019 | lymphoma | M.D. Anderson Cancer Center | Withdrawn | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT02114502 Background | Sep 2014 → Sep 2018 | plasma cell myeloma | M.D. Anderson Cancer Center | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Caphosol | “Control at our institution is 5cc sodium bicarbonate, 5cc rinsidin and 5cc of mycostatin 4 times daily for children. For adults it is Caphosol in the BMT unit and in the Basile...” NCT03399331 ↗7“This randomized phase III trial is studying how well Caphosol rinse works in preventing mucositis in young patients undergoing autologous or donor stem cell transplant.” NCT01305200 ↗ |
| Modality | Other / unclassified | “Caphosol is a topical oral agent of supersaturated calcium phosphate rinse indicated for dry mouth” NCT01046812 ↗ |
| Route | Oral | “Caphosol 2-4 times daily oral rinse” NCT01046812 ↗ |